Skip to main content

Clinical Trials › NCT04178005

Active, Not RecruitingPhase 4

Cladribine Tablets After Treatment With Natalizumab (CLADRINA)

Sponsored by University of Texas Southwestern Medical Center

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
40
Target enrollment
2
U.S. states
Feb 2020
Start date
Dec 2026
Expected completion

Interventions / Treatments

Cladribine

Conditions studied

Multiple Sclerosis

Where this trial is running (2 sites)

Kansas1 site
Overland Park
Texas1 site
Dallas

MS centers in Kansas

Compare treatment centers near a trial site by center type, providers and trials.

View Kansas centers

More Phase 4 trials

Browse all Phase 4 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play